Baimtec Material Co.,Ltd. (SHA:688563)
50.72
-0.33 (-0.65%)
At close: Jun 3, 2026
Baimtec Material Revenue
Baimtec Material had revenue of 658.02M CNY in the quarter ending March 31, 2026, with 0.79% growth. This brings the company's revenue in the last twelve months to 2.86B, down -1.49% year-over-year. In the year 2025, Baimtec Material had annual revenue of 2.86B, down -2.53%.
Revenue (ttm)
2.86B
Revenue Growth
-1.49%
P/S Ratio
7.94
Revenue / Employee
2.58M
Employees
1,109
Market Cap
22.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.86B | -74.05M | -2.53% |
| Dec 31, 2024 | 2.93B | 129.49M | 4.62% |
| Dec 31, 2023 | 2.80B | 467.28M | 20.01% |
| Dec 31, 2022 | 2.34B | 388.45M | 19.95% |
| Dec 31, 2021 | 1.95B | 494.41M | 34.04% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Construction Group | 214.78B |
| Tiandi Science & Technology Co.Ltd | 28.45B |
| Ningbo Sanxing Medical Electric | 13.97B |
| Jiangsu Phoenix Publishing & Media Corporation | 12.01B |
| Zhejiang Huahai Pharmaceutical | 8.55B |
| Xiamen Amoytop Biotech | 3.82B |
| Joinn Laboratories(China)Co.,Ltd. | 1.69B |
| The Pacific Securities | 1.27B |